Scaling Biosafety Up During and Down After the COVID-19 Pandemic
- PMID: 36761994
- PMCID: PMC9902049
- DOI: 10.1089/apb.2022.0008
Scaling Biosafety Up During and Down After the COVID-19 Pandemic
Abstract
Purpose: The aim of this work was to review and analyze changes to the practice of biosafety imposed by pandemics.
Methods: A narrative review of the COVID-19 pandemic that began in 2020 and prior pandemics from the perspective of a working virologist.
Results: By definition, pandemics, outbreaks, and other emergencies are transient phenomena. They manifest as waves of events that induce unforeseen needs and present unknown challenges. After a pandemic, the return to normality is as crucial as the scale-up during the exponential growth phase. The COVID-19 pandemic presents an example to study operational biosafety and biocontainment issues during community transmission of infectious agents with established pandemic potential, the propensity to induce severe disease, and the ability to disrupt aspects of human society.
Conclusions: Scaling down heightened biocontainment measures after a pandemic is as important as scaling up during a pandemic. The availability of preventive vaccines, and therapeutic drug regimens, should be considered in risk assessments for laboratory studies. There exists the need to preserve situational memory at the personal and institutional levels that can be served by professional societies.
Keywords: BSL-3; COVID; HIV; SARS-CoV-2; virus.
Copyright 2022, ABSA International 2022.
Conflict of interest statement
No competing financial interests exist.
Figures
Similar articles
-
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28. Int Rev Immunol. 2023. PMID: 35635216 Review.
-
Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh.J Infect Dev Ctries. 2021 Dec 31;15(12):1833-1837. doi: 10.3855/jidc.14415. J Infect Dev Ctries. 2021. PMID: 35044940
-
Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.Turk Psikiyatri Derg. 2021 Fall;32(3):219-221. doi: 10.5080/u26175. Turk Psikiyatri Derg. 2021. PMID: 34750798 English, Turkish.
-
Return-to-work, disabilities and occupational health in the age of COVID-19.Scand J Work Environ Health. 2021 Jul 1;47(5):408-409. doi: 10.5271/sjweh.3960. Epub 2021 May 18. Scand J Work Environ Health. 2021. PMID: 34003294 Free PMC article.
-
COVID-19: Prospective Challenges and Potential Vaccines.Altern Ther Health Med. 2020 Aug;26(S2):72-78. Altern Ther Health Med. 2020. PMID: 32845250 Review.
References
-
- Gallo RC, Sarin PS, Gelmann EP, et al. . Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science. 1983;220(4599):865–867. - PubMed
-
- Barre-Sinoussi F, Chermann JC, Rey F, et al. . Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220(4599):868–871. - PubMed
-
- Peck KM, Burch CL, Heise MT, et al. . Coronavirus host range expansion and Middle East respiratory syndrome coronavirus emergence: biochemical mechanisms and evolutionary perspectives. Annu Rev Virol. 2015;2(1):95–117. - PubMed
-
- Foster KR, Jenkins MF, Toogood AC. The Philadelphia yellow fever epidemic of 1793. Sci Am. 1998;279(2):88–93. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous